Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting June 8, 2026 11:00 AM EDT
Company Participants
Trang Ly – Senior VP & Chief Medical Officer
Conference Call Participants
Jeffrey Johnson – Robert W. Baird & Co. Incorporated, Research Division
Presentation
Jeffrey Johnson
Robert W. Baird & Co. Incorporated, Research Division
Good morning. Welcome to Baird and Insulet recap of the 86 session of the American Diabetes Association Annual Meeting. With us today, we’re thrilled to have Dr. Trang Ly, Senior Vice President and Chief Medical Officer; at Insulet. I do have to read one disclosure before we get started here, and that is to please refer to the event calendar published research or Baird’s website for important disclosures regarding the companies discussed during this event. Dr. Ly, good to see you. Thanks for doing this again.
Trang Ly
Senior VP & Chief Medical Officer
Great to see you Johnson.
Jeffrey Johnson
Robert W. Baird & Co. Incorporated, Research Division
Yes. Always a good time to go through this. I think we were talking to. It’s our sixth webcast, a few at ATTD, a few here at ADA. So it’s always a fun time.
Trang Ly
Senior VP & Chief Medical Officer
Always.
Question-and-Answer Session
Jeffrey Johnson
Robert W. Baird & Co. Incorporated, Research Division
All right. Well, let’s get started. First question. And unfortunately, we have to start here. But just on the recall that was announced a couple of weeks ago, second recall in 10 weeks. I’d love to just hear from you. You’re out there, I’m sure, talking to docs a lot over the last couple of weeks. Just how has the response been from the physician community and even the patient community, if you’ve touched anything there?
Trang Ly
Senior VP & Chief Medical
